Robuta

Sponsor of the Day: Jerkmate

https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.01704/full Frontiers | Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2... Apr 29, 2026 - While the SARS-CoV-2 pandemic is heavily hitting the world, it is of extreme importance that significant in vitro observations guide the quick set up of clin... anti sars cov therapeutic use frontiers combined prophylactic https://pandemics.utoronto.ca/resources/evidence-based-recommendations-on-the-use-of-anti-sars-cov-2-monoclonal-antibodies-casirivimab-imdevimab-and-sotrovimab-for-adults-in-ontario/ Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab +... anti sars cov evidence based monoclonal antibodies recommendations use https://www.biorxiv.org/content/10.1101/2021.03.16.435741v1 Structural basis of anti-SARS-CoV-2 activity of hydroxychloroquine: specific binding to NTD/CTD and... anti sars cov structural basis 2 activity hydroxychloroquine specific https://www.medrxiv.org/content/10.1101/2021.03.08.21253121v1 Absent or insufficient anti-SARS-CoV-2 S antibodies at ICU admission are associated to higher viral... anti sars cov absent insufficient 2 antibodies